The aim of the study is to evaluate differences in pregnancy outcomes and medical costs depending on gestational diabetes diagnostic criteria used (one vs two-step approach).
Due to Hyperglycemia and Adverse Pregnancy Outcomes study results, a new gestational diabetes mellitus (GDM) diagnostic criteria was defined using a one-step approach (75-g oral glucose tolerance test -OGTT-). However, not all scientific societies have accepted and have implanted this new diagnostic criteria. The lowest glycemia cut-off of this criteria regarding the two-step approach entails an increase in GDM incidence with discordant studies about its cost-effectivity. It will be assessed if pregnancy outcomes and medical costs are different depending on diagnostic criteria used.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Enrollment
3,644
One-step: 2 hr 75 gr OGTT
Osullivan test + 3 h 100 g OGTT
Hospital Universitari Mutua Terrassa
Terrassa, Barcelona, Spain
RECRUITINGLarge for gestational age
Infant birthweight \>90th centile using customized growth curves
Time frame: At birth of infant
Macrosomia
infant birthweight \>=4kg
Time frame: At birth of infant
Small for gestational age
infant birthweight \<10th centile using customized growth curves
Time frame: At birth of infant
Hypertension in pregnant
classification according to American College of Obstetricians and Gynecologists (Task Force on Hypertension in Pregnancy).
Time frame: First 3 months postpartum
Neonatal obstetric trauma
rate of shoulder dystocia, clavicle fracture, brachial plexus injury and intrapartum asphyxia
Time frame: At birth of infant
Congenital anomalies
Coding of EUROCAT
Time frame: At birth of infant
Neonatal hypoglycemia
neonatal plasma glucose levels of \<2.5 mmol/L in the first 24 hours of life and \<2.8 mmol/L thereafter.
Time frame: up to 4 weeks after delivery
Neonatal hypocalcemia
neonatal calcium levels of \<7mg/dl
Time frame: up to 4 weeks after delivery
Neonatal hyperbilirubinemia
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
hyperbilirubinemia treated with phototherapy
Time frame: up to 4 weeks after delivery
Neonatal polycythemia
hematocrit from a peripheral venous sample is \>65 percent
Time frame: up to 4 weeks after delivery
Respiratory Distress Syndrome
onset of progressive respiratory failure shortly after birth, in conjunction with a characteristic chest radiograph (after ruling out other causes).
Time frame: up to 4 weeks after delivery
Infant Outcomes
Pregnancy loss (Miscarriage, stillbirth, neonatal death)
Time frame: up to 4 weeks after delivery
Hypertrophic cardiomyopathy
increased left ventricular (LV) wall thickness ≥15 mm is imaged anywhere in the LV wall (by transthoracic echocardiography)
Time frame: up to 4 weeks after delivery
Polyhydramnios
Amniotic fluid index ≥25 cm
Time frame: At birth of infant
Gestational age at delivery
Gestational age was defined as completed weeks based on last menstrual period or the earliest ultrasound assessment if discordant.
Time frame: At birth of infant
Cesarean section
delivery of a baby through a surgical incision in the mother's abdomen and uterus
Time frame: At birth of infant
Perinatal mortality
infant deaths that occur at less than 7 days of age and fetal deaths with a gestational age of 28 weeks or more.
Time frame: First 7days postpartum
NICU admission
NICU admission for treatment or surveillance
Time frame: up to 4 weeks after delivery
Maternal hospital stay
Length of hospital stay (days)
Time frame: up to 4 weeks from maternal discharge
Neonatal hospital stay
Length of hospital stay (days)
Time frame: up to 4 weeks from neonatal discharge
Evaluation of mediterranean diet adherence
using Mediterranean Diet Adherence Screener (MEDAS) questionnaire. Score betwwen 0-14; high score indicate maximum mediterranean diet adherence.
Time frame: up to 12-14weeks from last menstrual period.
Evaluation of health-related physical activity
using International Physical Activity Questionnaire (IPAQ). Data collected with IPAQ can be used as a continuous measure (Metabolic Equivalent of Task \[MET\]-minutes/week) or caterorical measure (low, moderate or high physical activity)
Time frame: up to 12-14weeks from last menstrual period.
Medical cost
Economic cost include: laboratory costs; glucose bottles (50 g, 100 g and 75 g); pharmaceutical expenditure (exact insulin doses consumed, total pens, needles, strips); medical visits during pregnany and postpartum (endocrinologist,educational nurses, obstetrician and midwifes); total number of tests (ultrasonds, cardiotocography record); cost of intensive care unit admissions (Length of stay and complexity) and total hospital admission costs. All these variables will be expressed as cost (€).
Time frame: First 3 months postpartum